Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies
VJ Dzau, RC Braun-Dullaeus, DG Sedding - Nature medicine, 2002 - nature.com
In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall
inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that …
inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that …
Molecular basis of restenosis and drug-eluting stents
MA Costa, DI Simon - Circulation, 2005 - Am Heart Assoc
Next is a granulation or cellular proliferation phase. Growth factors are subsequently
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …
Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury
LE Otterbein, BS Zuckerbraun, M Haga, F Liu… - Nature medicine, 2003 - nature.com
Carbon monoxide (CO), one of the products of heme oxygenase action on heme, prevents
arteriosclerotic lesions that occur following aorta transplantation; pre-exposure to 250 parts …
arteriosclerotic lesions that occur following aorta transplantation; pre-exposure to 250 parts …
Heme oxygenase-1 protects against vascular constriction and proliferation
HJ Duckers, M Boehm, AL True, SF Yet, H San… - Nature medicine, 2001 - nature.com
Abstract Heme oxygenase (HO-1, encoded by Hmox1) is an inducible protein activated in
systemic inflammatory conditions by oxidant stress. Vascular injury is characterized by a …
systemic inflammatory conditions by oxidant stress. Vascular injury is characterized by a …
Cell cycle progression: new therapeutic target for vascular proliferative disease
RC Braun-Dullaeus, MJ Mann, VJ Dzau - Circulation, 1998 - Am Heart Assoc
Entry into and progression of vascular cells through the cell cycle is considered a key event
in vascular proliferative diseases. Multiple growth factors and cytokines have been found to …
in vascular proliferative diseases. Multiple growth factors and cytokines have been found to …
Cardiovascular gene therapy
S Ylä-Herttuala, JF Martin - The Lancet, 2000 - thelancet.com
Vascular gene transfer potentially offers new treatments for cardiovascular diseases. It can
be used to overexpress therapeutically important proteins and correct genetic defects, and to …
be used to overexpress therapeutically important proteins and correct genetic defects, and to …
Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation …
Understanding molecular mechanisms involved in vascular aging is essential to develop
novel interventional strategies for treatment and prevention of age-related vascular …
novel interventional strategies for treatment and prevention of age-related vascular …
Endothelial sprouting, proliferation, or senescence: tip** the balance from physiology to pathology
Therapeutic modulation of vascular cell proliferation and migration is essential for the
effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease. The …
effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease. The …
Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure
Cardiovascular events are the most frequent cause of death in patients with chronic renal
failure (1–2). Heterotopic calcification of blood vessel walls occurs frequently with advanced …
failure (1–2). Heterotopic calcification of blood vessel walls occurs frequently with advanced …
[HTML][HTML] A growth factor‐dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression
M Boehm, T Yoshimoto, MF Crook… - The EMBO …, 2002 - embopress.org
The cyclin‐dependent kinase inhibitor, p27 Kip1, which regulates cell cycle progression, is
controlled by its subcellular localization and subsequent degradation. p27 Kip1 is …
controlled by its subcellular localization and subsequent degradation. p27 Kip1 is …